Square Pharmaceuticals PLC. announcements
313 Dhaka Stock Exchange announcements for Square Pharmaceuticals PLC. (SQURPHARMA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (22).
- Credit Rating Information and Services Limited (CRISL) has rated the Company as \"AAA\" in the long term and \"ST-1\" in
Credit Rating Information and Services Limited (CRISL) has rated the Company as \"AAA\" in the long term and \"ST-1\" in the short term along with a stable outlook in consideration of its audited financials up to June 30, 2022; un-audited financial up to September 30, 2022 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Resumption after record date
Trading of the shares of the Company will resume on 29.11.2022 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 28.11.2022.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 24.11.2022 to 27.11.2022. Trading of the shares of the Company will remain suspended on record date i.e., 28.11.2022.
- Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 6.20 for July-September 2022 as against Tk. 5.64 for July-September 2021; Consolidated NOCFPS was Tk. 5.87 for July-September 2022 as against Tk. 6.61 for July-September 2021. Consolidated NAV per share was Tk. 122.84 as on September 30, 2022 and Tk. 116.70 as on June 30, 2022.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the company has informed that a meeting of the Board of Directors will be held on November 14, 2022 at 3:00 PM to consider, among others, un-audited financial statements of the company for the First Quarter (Q1) period ended September 30, 2022.
- The Board of Directors has recommended 100\% cash dividend for the year ended June 30, 2022. The Board has also approved
The Board of Directors has recommended 100\% cash dividend for the year ended June 30, 2022. The Board has also approved Tk. 300.00 crore for BMRE, Capital Machineries and Lands for future expansion. Date of AGM: 24.12.2022, Time: 10:00 AM, Venue: Digital Platform. Record Date: 28.11.2022. (cont.)
- Dividend Declaration and BMRE, Capital Machineries & Land purchase
(Continuation news of SQURPHARMA): The Company has also reported Consolidated EPS of Tk. 20.51, Consolidated NAV per share of Tk. 116.70 and Consolidated NOCFPS of Tk. 14.52 for the year ended June 30, 2022 as against Tk. 17.99, Tk. 102.54 and Tk. 12.38 respectively for the same period of the previous year. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (23.10.2022) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 20, 2022 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.
- The Company has informed that a fire broke out in the Large Volume Parenteral (LVP) Plant at the factory promises at Kal
The Company has informed that a fire broke out in the Large Volume Parenteral (LVP) Plant at the factory promises at Kaliakoir, Gazipur of the Company on May 23, 2022 at about 12.00 noon and was brought under control at about 11.00 p.m. by the hardworking of the 14 units of firefighting units, which was immediately broadcast and published by various broadcast and print media. It will cause the hampering of production of 50 (fifty) products by the company and reduce the revenue and profit by about (cont.)
- Regarding the Fire at the factory premises
Tk. 50.00 crore and Tk. 8.00 crore respectively. The ascertainment of damage in the fire is under active security by the tripartite team comprised of the experts of the company, firefighting units, and surveyors of insurance companies. However, the LVP plants is fully insured under the coverage of the Industrial All Risk Insurance Policy, and restoring the damaged facility and production may take 2/3 years. (end)
- Mr. Anjan Chowdhury, one of the Directors of the company, has further informed that he has completed his buying of 2,25,
Mr. Anjan Chowdhury, one of the Directors of the company, has further informed that he has completed his buying of 2,25,000 shares of the Company at prevailing market price through Dhaka Stock Exchange as per declaration disseminated on 07.04.2022.
- Mrs. Ratna Patra, one of the Directors of the company, has further informed that she has completed her buying of 2,25,00
Mrs. Ratna Patra, one of the Directors of the company, has further informed that she has completed her buying of 2,25,000 shares of the Company at prevailing market price through Dhaka Stock Exchange as per declaration disseminated on 07.04.2022.
- Mr. Tapan Chowdhury, one of the Directors of the company, has further informed that he has completed his buying of 2,25,
Mr. Tapan Chowdhury, one of the Directors of the company, has further informed that he has completed his buying of 2,25,000 shares of the Company at prevailing market price through Dhaka Stock Exchange as per declaration disseminated on 07.04.2022.
- Buy Confirmation of a Director
Mr. Samuel S Chowdhury, one of the Directors of the company, has further informed that he has completed his buying of 2,25,000 shares of the Company at prevailing market price through Dhaka Stock Exchange as per declaration disseminated on 07.04.2022.
- Q3 Financials
(Continuation news of SQURPHARMA): Consolidated NOCFPS increased the growth in there business volume and efficient utilization of working capital along with reduction in tax expense. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 27, 2022 at 2:15 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.
- Buy Declaration of a Director
Mrs. Ratna Patra, one of the Directors of the Company, has expressed her intention to buy 2,25,000 shares of the Company at prevailing market price (in the Public Market) through Dhaka Stock Exchange within April 28, 2022.
- Q2 Financials
(Continuation news of SQURPHARMA): The growth in business volume and efficient utilization of working capital along with reduction in tax expense resulted in increased consolidated NOCFPS. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 31, 2022 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2021.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2021 to the respective shareholders.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.